default:
  Name: "default"
  Signature:
    Up: NULL
    Down: NULL
    Score.method: "average"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: NULL
    Cell.type: NULL
    Tumor.type: NULL
    Species: NULL
  Article.info:
    First.Author: NULL
    Last.Author: NULL
    Journal: NULL
    Title: NULL
    Year: NULL
    DOI: NULL

ATATIL_2023_CD8_TR:
  Name: "ATATIL_2023_CD8_TR_v01"
  Signature:
    Up: "CXCL13, GAPDH, TNFRSF9, KLRC2, RPL12, PDCD1, ATP5MC2, TOX, MIF, SAMSN1, ITM2A, PARK7, RBPJ, LAG3, CTLA4, S100A4, IL6ST, PTPN6, CSNK2B, LYST" #  , RPL15, TMEM243, PTMA, PKM, UBE2F, FXYD5, DYNLL1, HOPX, DUSP4"
    Down: NULL
    Score.method: "AUCell"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Melanoma"
    Species: "Human"
  Article.info:
    First.Author: "Johanna Chiffelle"
    Last.Author: "Alexandre Harari"
    Journal: ""
    Title: ""
    Year: 2023
    DOI: ""

Hanada_2022_CD4_TR:
  Name: "Hanada_2022_CD4_TR_v01"
  Signature:
    Up: "CXCL13, NR3C1, ADGRG1, NMB, ITM2A, ETV7, COTL1, B2M, IGFL2"
    Down: "MT-ND1, MALAT1, VIM, EMP3"
    Score.method: NULL
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD4"
    Tumor.type: "Lung"
    Species: "Human"
  Article.info:
    First.Author: "Ken-ichi Hanada"
    Last.Author: "Steven A. Rosenberg"
    Journal: "Cancer Cell"
    Title: "A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers"
    Year: 2022
    DOI: "10.1016/j.ccell.2022.03.012"
    
Hanada_2022_CD8_TR:
  Name: "Hanada_2022_CD8_TR_v01"
  Signature:
    Up: "BATF, CXCL13, LAYN, ENTPD1, TIGIT, PHLDA1, GZMB, CD27, CD74, HLA-DMA, HLA-DRA, HLA-DRB1, HLA-DRP1, CD82, CD3D, ARL3, CCND2, TPI1, GAPDH, ALOX5AP, LSP1, ITM2A, CARS, DUSP4, HMOX1, HMGN3, CHST12, NAP1L4"
    Down: "IL7R"
    Score.method: NULL
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Lung"
    Species: "Human"
  Article.info:
    First.Author: "Ken-ichi Hanada"
    Last.Author: "Steven A. Rosenberg"
    Journal: "Cancer Cell"
    Title: "A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers"
    Year: 2022
    DOI: "10.1016/j.ccell.2022.03.012"

Li_2018_CD8_Exhaustion:
  Name: "Li_2018_CD8_Exhaustion_v01"
  Signature:
    Up: "LAG3, HAVCR2, PDCD1, PTMS, FAM3C, IFNG, AKAP5, CD7, PHLDA1, ENTPD1, SNAP47, TNS3, CXCL13, RDH10, DGKH, KIR2DL4, LYST, MIR155HG, RAB27A, CSF1, CTLA4, TNFRSF9, CD27, CCL3, ITGAE, PAG1, TNFRSF1B, GALNT1, GBP2, MYO7A"
    Down: NULL
    Score.method: NULL
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Exhaustion"
    Cell.type: "CD8"
    Tumor.type: "Melanoma"
    Species: "Human"
  Article.info:
    First.Author: "Hanjie Li"
    Last.Author: "Ton N. Schumacher"
    Journal: "Cell"
    Title: "Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma"
    Year: 2019
    DOI: "10.1016/j.cell.2018.11.043"

Lowery_2022_CD4_TR:
  Name: "Lowery_2022_CD4_TR_v01"
  Signature:
    Up: "CXCL13, HMOX1, ETV7, ADGRG1, PDCD1, ENTPD1, CCDC50, TOX, CD4, TIGIT, TNFRSF18, NMB, MYL6B, AHI1, MAF, IFNG, LAG3, CXCR6, IGFLR1, DUSP4, ACP5, LINC01943, LIMS1, BATF, PCED1B, ITGAL, YPEL2, MAL, PPT1, ELMO1, MIS18BP1, TMEM173, ADI1, SLA, GALM, LBH, SECISBP2L, CTSB, C17orf49, CORO1B"
    Down: NULL
    Score.method: "scGSEA"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD4"
    Tumor.type: "Melanoma, Breast, Colon"
    Species: "Human"
  Article.info:
    First.Author: "Frank J. Lowery"
    Last.Author: "Steven A. Rosenberg"
    Journal: "Cancer Immunology"
    Title: "Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers"
    Year: 2022
    DOI: "10.1126/science.abl5447"

Lowery_2022_CD8_TR:
  Name: "Lowery_2022_CD8_TR_v01"
  Signature:
    Up: "ATP10D, GZMB, ENTPD1, KIR2DL4, LAYN, HTRA1, CD70, CXCR6, HMOX1, ADGRG1, LRRN3, ACP5, CTSW, GALNT2, LINC01480, CARS, LAG3, TOX, PTPRCAP, ASB2, ITGB7, PTMS, CD8A, GPR68, NSMCE1, ABI3, SLC1A4, PLEKHF1, CD8B, LINC01871, CCL4, NKG7, CLIC3, NDFIP2, PLPP1, PCED1B, CXCL13, PDCD1, PRF1, HLA-DMA, GPR25, CD9, TIGIT, HLA-DRB5, SYTL3, SLF1, NEK1, CASP1, SMC4, TSEN54, PLSCR1, GNPTAB, HLA-DPB1, PLEKHA1, ARHGAP9, ALOX5AP, SH3BP1, NCF4, NELL2, GATA3, PPM1M, TNFRSF1A, AC022706.1, MCM5, HLA-DRB1, TNFSF10, TRIM21, HDLBP, ERN1, CALHM2, SASH3, ACTA2, MAST4, CAPG, MPST, IGFLR1, GZMA, CD27, ITGAE, SLA2, RHOC, COMMD8, MYO1G, SP140, PHPT1, CD2BP2, PLEKHO1, STAM, MRPL16, IL2RB, ID2, TESPA1, GOLGA8B, MIS18BP1, VAMP5, DAPK2, HLA-DPA1, TSG101, IL4R, CCND2, CTSC, TRAF3IP3, NLRC3, ORAI3, GNLY, MIR155HG, CARD16, CD82, ECH1, JAML, EEF1G, ETFB, DAXX, RBM4, HCST, RAB27A, YPEL2, CHST12, ARPC1B, PDIA4, PDIA6, AC243960.1, TBC1D10C, PTPN6, PYCARD, BST2, BTN3A2, MTG1, MLEC, DUSP4, GSDMD, SLAMF1, IFI6, PCID2, GIMAP1, ITGA1, CSNK2B, CDK2AP2, MYO1F, AC004687.1, PTTG1, APOBEC3C, TSPAN14, MOB3A, STXBP2, LCP2, PLA2G16, LINC00649, CST7, TADA3, SIT1, APOBEC3G, SUSD3, CD3G, CCL5, CDC25B, TNFRSF1B, HMGN3, THEMIS, ASF1A, CTNNB1, FIBP, CCDC85B, POLR3GL, GIMAP6, ARL6IP1, CALCOCO2, CCPG1, KLRB1, ACAA2, ISG15, EIF4A1, CAT, MANF, XAB2, GRINA, GLO1, LSM2, SLFN5, FKBP1A, AKNA, TAP1, LMO4, APEH, C12orf75, TMEM14A, DNPH1, C17orf49, NUDT5, MGAT1, CCDC69, EIF4EBP1, PDHB, ARL3, UCP2, IFI35, HSBP1, LYST, MRFAP1L1, ITGAL, AIP, RASAL3, CAPN1, ITGB1, RBPJ, LBH, DYNLL1, NME2, MT1F, SYNGR2, ABTB1, ZGPAT, CD63, ILK, SKA2, TMEM204, ACO2, HOPX, CRIP1, OXNAD1, CCS, GRAP2, GSTO1, HADHB, IL16, PIN4, CUEDC2, CALM3, SAMSN1, HM13, SNAP23, LPCAT4, FAAP20, EFHD2, PRDX3, CCM2, C22orf39, SDHA, ARRDC1, MAP4K1, NDUFA13, IL27RA, C14orf119"
    Down: NULL
    Score.method: "scGSEA"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Melanoma, Breast, Colon"
    Species: "Human"
  Article.info:
    First.Author: "Frank J. Lowery"
    Last.Author: "Steven A. Rosenberg"
    Journal: "Cancer Immunology"
    Title: "Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers"
    Year: 2022
    DOI: "10.1126/science.abl5447"

Oliveira_2021_CD8_TR:
  Name: "Oliveira_2021_CD8_TR_v01"
  Signature:
    Up: "KRT86, RDH10, TYMS, HMOX1, GNG4, CXCL13, AFAP1L2, ACP5, MYO1E, LAYN, TNS3, TNFSF4, AKAP5, HAVCR2, ENTPD1, SLC2A8, AC243829.4, ZBED2, MCM5, CAV1, GOLIM4, TRAV21, VCAM1, PON2, MTSS1, CD38, TRBV11-2, MS4A6A, TOX2, CSF1, GALNT2, FXYD2, PLPP1, LMCD1, MYL6B, LAG3, HLA-DRA, IGFLR1, CCDC50, CD27, KIAA1324, CDKN2A, CD70, ABHD6, CTLA4, PDCD1, GEM, NUSAP1, TOX, CXCR6, NMB, HOPX, CLIC3, INPP5F, SNAP47, TSHZ2, HLA-DMA, SIT1, HLA-DRB1, TUBB, PYCARD, ADGRG1, HLA-DQA1, PRF1, HLA-DPA1, PTMS, CKS1B, HIPK2, CHST12, LSP1, FAM3C, SLC1A4, NUDT1, DNPH1"
    Down: "RARA, GADD45B, C1orf21, AOAH, MATK, SATB1, MBP, ANTXR2, RORA, CCR7, ANXA1, BACH2, GLUL, TNFSF14, AUTS2, PERP, EPHA4, TCF7, SELL, MYC, IL7R, CD300A, ITGA5, GPR183, KLF3, S1PR1, FOSB"
    Score.method: "average"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Melanoma"
    Species: "Human"
  Article.info:
    First.Author: "Giacomo Oliveira"
    Last.Author: "Catherine J. Wu"
    Journal: "Nature"
    Title: "Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma"
    Year: 2021
    DOI: "10.1038/s41586-021-03704-y"

Van_der_Leun_2020_CD8_TR:
  Name: "Van_der_Leun_2020_CD8_TR_v01"
  Signature:
    Up: "ENTPD1, ITGAE, PDCD1, TNFRSF9, TNFRSF4, CXCL13, MKI67, HAVCR2, LAG3"
    Down: NULL
    Score.method: NULL
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "None"
    Species: "Human"
  Article.info:
    First.Author: "Anne M. van der Leun"
    Last.Author: "Ton N. Schumacher"
    Journal: "Nature"
    Title: "CD8+ T cell states in human cancer: insights from single-cell analysis"
    Year: 2020
    DOI: "10.1038/s41568-019-0235-4"

Zheng_2022_CD4_TR:
  Name: "Zheng_2022_CD4_TR_v01"
  Signature:
    Up: "CD7, ENSG00000226899, ENSG00000281383, ENSG00000225840, ENSG00000233139, ENSG00000280614, ENSG00000281181, ENSG00000280800, HOPX, MAL, ADGRG1, SRGAP3, CTSD, GDPGP1, TGFBI, PDE7B, IFITM2, LINC01480, ENSG00000277089, TMED2, CCND2, LINC01871, IL2RB, ZNF8, LAIR2, CCL15, HLA-H, CD3E, TOX2, PLPP1, CEP89, C15orf39, TNFRSF18, SH2D2A, ADAM28, RHOC, ASXL2, MT-ND4L, CTNNA1, AZIN2, ENSG00000262202, GZMB, CCL15-CCL14, ENTPD1, VAPA, PRKAR1A, ATP8B4, CCL23, NCALD, ATP1B1, CTNND1, MAP3K8, ANKRD54, CBFB, CSF1, ZFP36L1, TNFAIP8L1, PDE4DIP, ABCA2, LILRP2, ERP44, LAT2, ENSG00000256966, NELL2, LAYN, NKIRAS2, ZBTB38, BACH2, KRT86, TIGIT, ZNF268, IKZF4, BORCS8, BCL2L11, CDC14A, PIGT, PDCD1, LRBA, ZNF75A, SYNGR2, ZDHHC4, ATM, TIAM1, SMOX, CADM1, HDAC7, THOC5, ANKRD36BP1, CTC1, SMG1P3, HINFP, SETX, PRF1, CLSTN3, HUWE1, TOX, SQSTM1, DCUN1D1"
    Down: NULL
    Score.method: "average"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD4"
    Tumor.type: "Gastrointestinal"
    Species: "Human"
  Article.info:
    First.Author: "Chunhong Zheng"
    Last.Author: "Eric Tran"
    Journal: "Cancer Cell"
    Title: "Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers"
    Year: 2022
    DOI: "10.1016/j.ccell.2022.03.005"

Zheng_2022_CD8_TR:
  Name: "Zheng_2022_CD8_TR_v01"
  Signature:
    Up: "CXCL13, RBPJ, NR6A1, SPATA4, KRT86, TC2N, RGS1, CSGALNACT1, STOM, GZMK, MT-CO2, MT-ND3, LRRN3, ETV1, CD3D, MT-ND1, GTF2IP13, TBC1D4, MT-ND4L, XIST, IQGAP1, ITM2C, PHLDA1, CARD16, MT-CO3, UBL5, AOAH, HSPA7, TOX, MIR155HG, HSPA6, LYST, AUTS2, MT-ND4, SERF2, MT-ATP6, RPS4Y1, NELL2, ENSG00000196656, RPL10P9, BPESC1, LAYN, CHN1, SRI, POLR2G, MTND2P28, MTATP6P1, MT-ND2, CCL3L1, NR3C1, SLAMF7, SEC61G, MT-RNR2, MT-ND5, GOLIM4, HECTD2, PCED1B-AS1, LINC00299, CTLA4, ENSG00000260342, MT-ATP8, HAVCR2, ID2, TMSB10, GPM6A, IL7R, CCL4L2, CRIP1, TXLNGY, IL6ST, MT-CYB, SIRPG, COMMD6, TNFRSF18, DDX3Y, MRPL33, RNF19A, SLC4A7, RUNX2, SLA, MYC, GCHFR, LINC-PINT, ENSG00000273247, RPL21, DHRS3, TIGIT, SYNGR1, SYNGR2, MYADM, NDUFA3, LINC02446, FAM157A, BTLA, NAP1L4, KDM5D, RPL41, RPS28, TMA7, CARS, CD55, MYL6, LINC00158, EID1, HSPA1A, PIK3CD, NHS, THRAP3, CCND2, TSTD1, RPL21P16, DGKZ, IL2RA, CD200, HIPK2, BST2, TSPAN13, PITPNC1, CAPG, MS4A6A"
    Down: NULL
    Score.method: "average"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Gastrointestinal"
    Species: "Human"
  Article.info:
    First.Author: "Chunhong Zheng"
    Last.Author: "Eric Tran"
    Journal: "Cancer Cell"
    Title: "Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers"
    Year: 2022
    DOI: "10.1016/j.ccell.2022.03.005"


Krishna_2023_NeoTCR:
  Name: "Krishna_2023_NeoTCR_v01"
  Signature:
    Up: "" 
    Down: NULL
    Score.method: NULL
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Colon"
    Species: "Human"
  Article.info:
    First.Author: "Sri Krishna"
    Last.Author: "Steven A Rosenberg"
    Journal: "US Patent"
    Title: "Methods of isolating T.cells and T-cell receptors from tumor by single-cell analysis for immunotherapy"
    Year: 2023
    DOI: NULL


CrOv_9pat_CD8_FDR5_TR:
  Name: "CrOv_9pat_CD8_FDR5_TR_v01"
  Signature:
    Up: "HLA-DQA2, KIR2DL4, MTCO1P12, TRGV9, HLA-H, PELI1, TNFRSF9, KRT86, LAG3, DUSP4, HLA-DRB5, TYROBP, ELL2, ENSG00000228509, CCL3L1, ENSG00000280138, NR4A2, CXCL13, MAP3K8, MT2A, HLA-DQB1, SEC14L1, ZNF331, CCL3, PMAIP1, CREM, OASL, HLA-DRA, FAM177A1, RNF19A, ADGRE5, LITAF, TUBA4A, EPC1, HLA-DRB1, EZR, CD74, HSPA5, CD7, PNRC1, HLA-DPA1, HLA-DPB1, UBB, NKG7, EIF1, RPS26, UBC, FTL, GAPDH, H3-3B, RPL8, HLA-C, HLA-A" 
    Down: "ACTB, MT-CO1, CD52, FOS, CD69, MYL12A, MT-ATP6, S100A4, MT-ND4L, PLAAT4, S100A11, ITM2B, LCP2, ENO1, RESF1, CCL4, ARPC5, ACTR3, CTSC, CD2, LCK, CSTB, CCND3, RBL2, IL7R, FKBP5, CAPG, TMOD3, DENND2D, SELPLG, TC2N, ENSG00000224114, RGL4, GIMAP4, THEMIS, GIMAP7, CISH, KLRB1, KLRG1, ENSG00000213058"
    Score.method: "AUCell"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Ovarian-Colon"
    Species: "Human"
  Article.info:
    First.Author: ""
    Last.Author: ""
    Journal: ""
    Title: ""
    Year: NULL
    DOI: NULL

CrOv_9pat_CD8_FDR1_posl2FC05_TR:
  Name: "CrOv_9pat_CD8_FDR1_posl2FC05_TR_v01"
  Signature:
    Up: "HLA-DQA2, KIR2DL4, MTCO1P12, TRGV9, HLA-H, PELI1, TNFRSF9, KRT86, LAG3, DUSP4, HLA-DRB5, ELL2, NR4A2, CXCL13, MAP3K8, MT2A, HLA-DQB1, ZNF331, CCL3, PMAIP1, CREM, HLA-DRA, FAM177A1, RNF19A, ADGRE5, TUBA4A, HLA-DRB1" 
    Down: NULL
    Score.method: "AUCell"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Ovarian-Colon"
    Species: "Human"
  Article.info:
    First.Author: ""
    Last.Author: ""
    Journal: ""
    Title: ""
    Year: NULL
    DOI: NULL

CrOv_9pat_CD8_FDR1_l2FC05_TR:
  Name: "CrOv_9pat_CD8_FDR1_l2FC05_TR_v01"
  Signature:
    Up: "HLA-DQA2, KIR2DL4, MTCO1P12, TRGV9, HLA-H, PELI1, TNFRSF9, KRT86, LAG3, DUSP4, HLA-DRB5, ELL2, NR4A2, CXCL13, MAP3K8, MT2A, HLA-DQB1, ZNF331, CCL3, PMAIP1, CREM, HLA-DRA, FAM177A1, RNF19A, ADGRE5, TUBA4A, HLA-DRB1" 
    Down: "S100A11, ITM2B, LCP2, ENO1, CCL4, ACTR3, CD2, LCK, CCND3, FKBP5, CAPG, SELPLG, ENSG00000224114, RGL4, GIMAP4, THEMIS, GIMAP7, CISH, KLRB1, KLRG1, ENSG00000213058"
    Score.method: "AUCell"
    Score.threshold: NULL
  Signature.info: 
    Phenotype: "Tumor-Reactivity"
    Cell.type: "CD8"
    Tumor.type: "Ovarian-Colon"
    Species: "Human"
  Article.info:
    First.Author: ""
    Last.Author: ""
    Journal: ""
    Title: ""
    Year: NULL
    DOI: NULL


